SICHUAN KELUN-BIOTECH BIOPHARMACEUT earnings per share and revenue

6990 earnings per share for the last semiannual are -2.59 HKD whereas the estimation was -2.69 HKD which accounts for 3.87% surprise. Company revenue for the same period amounts to 566.26 M HKD despite the estimated figure of 500.43 M HKD. Estimated earnings per share for the next semiannual are -0.65 HKD, and revenue is expected to reach 1.12 B HKD. Also watch annual changes over time to get a bigger picture of 6990 earnings per share and revenue dynamics.